Rare cancer

• Personal Stories
• Health & Medicine

Li Fraumeni Syndrome and the start of precision cancer prevention

We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li Fraumeni Syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease. We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li Fraumeni Syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease.

19 September 2023

• Personal Stories

How keeping active during cancer treatment has helped Mary and Keith

It’s well known that exercise reduces cancer risk, but can it make any difference for people living with cancer? Read Mary and Keith's stories. It’s well known that exercise reduces cancer risk, but can it make any difference for people living with cancer? Read Mary and Keith's stories.

26 September 2022

• Science & Technology

Thinking outside the box to tackle an aggressive children’s cancer

How our partnership with Children with Cancer UK is helping to transform our understanding of children’s and young people’s cancers. How our partnership with Children with Cancer UK is helping to transform our understanding of children’s and young people’s cancers.

8 September 2021

• Science & Technology

Personalised treatments for rare cancers tested in study

A small new trial in the US has suggested personalised treatment based on tumour features could be effective in patients with rare cancers. A small new trial in the US has suggested personalised treatment based on tumour features could be effective in patients with rare cancers.

17 October 2017